Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study.
Title: | Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study. |
---|---|
Authors: | Mortimer, Joanne E., Bading, James R., Frankel, Paul H., Carroll, Mary I., Yuan, Yuan, Park, Jinha M., Tumyan, Lusine, Gidwaney, Nikita, Poku, Erasmus K., Shively, John E., Colcher, David M. |
Source: | Journal of Nuclear Medicine; Dec2021, Vol. 62 Issue 12, p1-15, 28p |
Database: | Complementary Index |
ISSN: | 01615505 |
---|---|
DOI: | 10.2967/jnumed.121.262940 |
Published in: | Journal of Nuclear Medicine |
Language: | English |